partners

Partnering to diversify and strengthen our product pipeline.

We form mutually beneficial alliances that allow us to license assets, share capabilities, knowledge and ultimately profits from products we develop. Strategic partnerships give us the ability to generate revenues that allow us to advance on a number of different projects, enabling increased breadth and diversity of our pipeline.

As pharmaceutical companies continue to search for assets that compliment their own pipelines, we will continue to seek out and evaluate partnership opportunities.

Interested in partnering with Xenon? Contact us >

Partnerships

Novartis Merck  Roche Takeda  Isis Pharma
CDRD Genome British Columbia Genentech Teva uniQure